ArticleAmerican journal of respiratory and critical care medicine2019

YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib.

Irati Garmendia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.